|

MMF Immunosuppression Clinical Trials

3 actively recruiting trials

Pipeline

Early 1: 3

Top Sponsors

  • Wondercel Biotech (ShenZhen)3

Indications

  • Cancer3
  • Liver Disease1
  • Refractory and Relapsed Multiple Myeloma1
  • Multiple Myleoma1
  • B-Cell Leukemia1

Other3 trials

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Early 1
Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
Early 1
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.